In this study, we built a model of brain ischemia–reperfusion to observe whether the SLC7A11/GSH/GPX4 and PDGFRβ/PIK/Akt signal pathways were involved in the process; most importantly, we evaluated whether these two pathways could be potential valid targets of DL-NBP treatment. The gene discussed is PDGFRB; the disease is brain ischemia.